![]() ![]() However, they did not need specialised medical care. The patients had symptoms that included fever, headaches, and muscle aches. Israel's head of public health, Dr Sharon Alroy-Preis, has stated that the occurrence of combined variants is a well-known phenomenon, and there is no current cause for concern regarding any severe cases resulting from this new variant. ![]() So far, two cases of the said new variant has been found and both were tested upon landing at Ben-Gurion International airport. Though the new variant was detected in Israel, initial findings suggest it did not originate in the country. Now scientists in Israel have claimed that they have discovered a yet-to-be-identified virus variant.Īccording to Israel's health ministry, the new variant combines two sub-variants of the Omicron version of the virus, referred to as BA.1 and BA.2. Combination of two Omicron sub-variants.In their conclusion, the researchers said, “HCQ is effective in reducing risk of Covid-19, at 800 mg loading and 400 mg weekly dose with more than 2 weeks dosing. Incidentally, Donald Trump, who tested positive for Covid-19 in October, recovered fast from the coronavirus infection without showing any serious complication. Only five or six got infected with SARS-CoV-2 in Bhagalpur but none developed serious complications, and nobody died of Covid-19,” Dr Raj Kamal Choudhry told Indiatoday.in. “Of 2,700 people who were given HCQs, 700 were doctors. ![]() Only those patients who were in ICU were not given.” Later, we gave this drug to all who had mild cases. ![]() Those who took this drug did not have Covid excepting 5 and 6. “We did not give to those who had palpitations and had QT prolongation. HCQ’s anti-viral properties were known.”ĭr Raj Kamal Choudhry, who was the nodal officer for the prophylaxis study of HCQ in Bihar’s Bhagalpur medical college, said, “We had given about 2,700 doctors and paramedical staff, laundry and kitchen people the prophylaxis of HCQs in the dose of HCQs 400 mg 1≲ for first day then 1 tab daily for 4 days.” One of the co-authors of the study, Dr Raj Kamal Choudhry said, “In the 1985-86 edition of Harrison's Principles of Internal Medicine, Dr Fauci wrote that HCQ worked an anti-viral agent despite being an anti-malarial drug. The study was conducted in May-September last year across 44 hospitals in 17 states involving hundreds of doctors, who received doses of hydroxychloroquine. The authors of this prophylactic (relating to prevention of a disease) study said that this “is the largest multicenter study on HCQ prophylaxis on HCWs (healthcare workers), covering over 12,000 HCWs at the risk of Covid-19”. The ICMR guidelines prescribed the use of hydroxychloroquine in mild cases of Covid-19. The government’s revised guidelines, however, contradicts the recommendations made by the Indian Council of Medical Research as released on May 17. The government’s decision came on the back of criticism by experts who pointed out a lack of study-based evidence to recommend hydroxychloroquine in Covid-19 cases. In its nine-page guidelines released on Sunday (June 6) by the directorate of health services, hydroxychloroquine, ivermectin and favipiravir find no mention. Incidentally, the Union health ministry on June 6 dropped hydroxychloroquine from Covid-19 treatment protocol. ![]()
0 Comments
Leave a Reply. |